reaches $56 million settlement over faulty hip replacements
Send a link to a friend
[February 04, 2014]
Biomet Inc, a U.S. medical device maker, will
pay at least $56 million to settle a multi-district lawsuit relating
to defective metal hip replacements, a court filing showed, ending a
protracted legal tussle.
The litigation involves Biomet's metal-on-metal hip
replacement device known as M2a Magnum. Hundreds of plaintiffs
claimed in various courts across the country that the hip device led
The lawsuits were combined and jointly heard at the federal court of
Indiana, the state where Biomet is headquartered. The multi-district
litigation began in 2012.
As part of the settlement, Biomet will deposit $50 million into an
escrow account and another $6 million into an attorney fee fund, the
The agreement with the plaintiffs shall extend to all pending cases,
and any future lawsuit filed in a federal court on or before April
Plaintiffs who have received a Biomet M2a 38 or M2a Magnum hip
replacement system as part of an initial hip replacement that was
rectified more than 180 days after it was implanted shall receive a
base award of $200,000.
Biomet, however, maintains that the injuries, losses and damages
were not due to its hip implants.
"Plaintiffs and Biomet are mindful of the uncertainties engendered
by litigation and are desirous of settling and compromising their
differences by entering into this settlement agreement," Judge
Robert Miller wrote in his order.
[to top of second column]
Biomet said in a statement late on Monday that it is pleased to
reach a settlement and resolve the lawsuits.
The case is Biomet M2A Magnum Hip Implant Products Liability
Litigation (MDL 2391), Case No. 12-02391, U.S. District Court,
Northern District of Indiana.
(Reporting by Sakthi Prasad in
Bangalore; editing by Supriya Kurane)
[© 2014 Thomson Reuters. All rights
Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.